In addition, not only hematological cancer cell lines but also normal B lymphocytes are sensitive to BAPTAi, which correlates with their sensitivity toward MCL-1 inhibition. The gene discussed is MCL1; the disease is hematopoietic and lymphoid cell neoplasm.